Page 129 - GPD-3-4

Gene & Protein in Disease PIVKA-II in differential diagnosis of AFP-NHCC

38. Patten DA, Wilkinson AL, O’Keeffe A, Shetty S. Scavenger brachytherapy in primary liver cancer. J Cancer Res Clin
receptors: Novel roles in the pathogenesis of liver Oncol. 2023;149(12):9777-9786.
inflammation and cancer. Semin Liver Dis. 2022;42(1):61-76.
doi: 10.1007/s00432-023-04875-z
doi: 10.1055/s-0041-1733876 48. Suner A, Carr BI, Akkiz H, et al. C-reactive protein and
39. Bishayee A. The role of inflammation and liver cancer. Adv platelet-lymphocyte ratio as potential tumor markers in
Exp Med Biol. 2014;816:401-435. low-alpha-fetoprotein hepatocellular carcinoma. Oncology.
2019;96(1):25-32.
doi: 10.1007/978-3-0348-0837-8_16
doi: 10.1159/000492473
40. Lee FY, Lee SD, Tsai YT, Wu JC, Lai KH, Lo KJ. Serum
C-reactive protein as a serum marker for the diagnosis of 49. Li K, Xu Y, Hu Y, Liu Y, Chen X, Zhou Y. Effect of enteral
hepatocellular carcinoma. Cancer. 1989;63(8):1567-1571. immunonutrition on immune, inflammatory markers and
nutritional status in gastric cancer patients undergoing
doi: 10.1002/1097-0142(19890415)63:8<1567:aid-cncr2820 gastrectomy: A randomized double-blinded controlled trial.
630820>3.0.co;2-j J Invest Surg. 2020;33(10):950-959.
41. Gomez D, Farid S, Malik HZ, et al. Preoperative neutrophil- doi: 10.1080/08941939.2019.1569736
to-lymphocyte ratio as a prognostic predictor after curative
resection for hepatocellular carcinoma. World J Surg. 50. Milana F, Polidoro MA, Soldani C, et al. Unveiling the
2008;32(8):1757-1762. prognostic role of blood inflammatory indexes in a retrospective
cohort of patients undergoing liver resection for intrahepatic
doi: 10.1007/s00268-008-9552-6 cholangiocarcinoma. Int J Surg. 2024;110(11):7088-96.
42. Wang Y, Attar BM, Fuentes HE, Jaiswal P, Tafur AJ. Evaluation doi: 10.1097/JS9.0000000000001924
of the prognostic value of platelet to lymphocyte ratio in
patients with hepatocellular carcinoma. J Gastrointest Oncol. 51. Choi Y, Kim JW, Nam KH, et al. Systemic inflammation is
2017;8(6):1065-1071. associated with the density of immune cells in the tumor
microenvironment of gastric cancer. Gastric Cancer.
doi: 10.21037/jgo.2017.09.06 2017;20(4):602-611.
43. Xu ZG, Ye CJ, Liu LX, et al. The pretransplant neutrophil- doi: 10.1007/s10120-016-0642-0
lymphocyte ratio as a new prognostic predictor after liver
transplantation for hepatocellular cancer: A systematic 52. Degasperi E, Perbellini R, D’Ambrosio R, et al. Prothrombin
review and meta-analysis. Biomark Med. 2018;12(2):189-199. induced by vitamin K absence or antagonist-II and alpha
foetoprotein to predict development of hepatocellular
doi: 10.2217/bmm-2017-0307 carcinoma in Caucasian patients with hepatitis C-related
44. Vucur M, Ghallab A, Schneider AT, et al. Sublethal cirrhosis treated with direct-acting antiviral agents. Aliment
necroptosis signaling promotes inflammation and liver Pharmacol Ther. 2022;55(3):350-359.
cancer. Immunity. 2023;56(7):1578-1595.e8. doi: 10.1111/apt.16685
doi: 10.1016/j.immuni.2023.05.017 53. Akuta N, Kawamura Y, Suzuki F, et al. Dynamics of circulating
45. Wang H, Zhang B, Li R, et al. KIAA1199 drives immune miR-122 predict liver cancer and mortality in japanese
suppression to promote colorectal cancer liver metastasis patients with histopathologically confirmed NAFLD and
by modulating neutrophil infiltration. Hepatology. severe fibrosis stage. Oncology. 2022;100(1):31-38.
2022;76(4):967-981. doi: 10.1159/000519995
doi: 10.1002/hep.32383 54. Zhang Z, Zhang Y, Wang Y, Xu L, Xu W. Alpha-fetoprotein-L 3
46. Guo Y, Hu HT, Xu SJ, et al. Correlation of serum chemokine and golgi protein 73 may serve as candidate biomarkers
ligand 14 with barcelona clinic liver cancer stage, lymphocyte for diagnosing alpha-fetoprotein-negative hepatocellular
profile, and response to transarterial chemoembolization carcinoma. Onco Targets Ther. 2016;9:123-139.
in patients with hepatocellular carcinoma. J Vasc Intervr doi: 10.2147/ott.S90732
Radiol. 2023;34(6):991-998.
55. Zhu L, Li T, Ma X, et al. A simple noninvasive index can
doi: 10.1016/j.jvir.2023.01.032 predict hepatocellular carcinoma in patients with chronic
hepatitis B. Sci Rep. 2017;7(1):8954.
47. Kastle S, Stechele MR, Richter L, et al. Peripheral blood-
based cell signature indicates response to interstitial doi: 10.1038/s41598-017-09358-z

Volume 3 Issue 4 (2024) 10 doi: 10.36922/gpd.4269